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ABSTRACT 
Objective: The objectives of this study were to investigate the cytotoxic effects of extracts and fractions of Albizia zygia roots (AZR) on human T-
lymphoblast-like leukemia (Jurkat), prostate cancer (LNCap) and breast cancer (MCF-7) cells and the apoptotic effect in Jurkat cells. 
Methods: Aqueous and hydroethanolic extracts were prepared and tested for cytotoxic effects on the cell lines using the tetrazolium-based 
colorimetric assay. Apoptosis induction was determined by DNA fragmentation, cell morphological changes, flow cytometric and mitochondrial 
membrane potential assays. 
Results: Both aqueous and hydroethanolic extracts were more cytotoxic to Jurkat cells than the other cell lines, with selective index (SI) values of 104.4 and 
86.6, respectively. The SI values of the extracts on LNCap cells were 9.0 and 35.4, respectively. Some of the fractions were non-cytotoxic. Nevertheless 
petroleum ether fraction was cytotoxic towards MCF-7 cells with SI value of 2.4. The hydroethanolic extract exhibited apoptosis via induction of DNA 
fragmentation in Jurkat cells. Cell morphological changes were consistent with the extract-mediated cytotoxicity and DNA fragmentation. Flow cytometric 
and mitochondrial membrane potential assays also showed significant apoptotic induction confirming apoptosis by the AZR extract.  
Conclusion: This study has shown that AZR possesses anticancer activity by demonstrating a high selective toxicity against Jurkat cells. 
Furthermore, the hydroethanolic extract induced apoptosis in the Jurkat cells. Albizia zygia roots may be a source of novel compounds for the 
development of new anti-cancer agents. 
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INTRODUCTION 
Albizia zygia (DC) J. F. Macbr is a plant that belongs to the family 
Leguminosae subfamily Mimosoideae. It is a gum producing plant, 
which is commonly found in West Africa [1]. Pharmacological 
properties of Albizia species include activities against inflammatory 
conditions such as tumours, asthma, arthritis, boils, bronchitis, ulcers 
and leprosy [2, 3]. In Southern Sudan, Traditional Medicine 
Practitioners use the aqueous decoction of the powdered bark of the 
plant to treat malaria and other parasitic infections [2, 3]. Species of 
the genus Albizia have different classes of secondary metabolites 
including saponins, terpenes, alkaloids and flavonoids. Some bioactive 
compounds from genus Albizia are triterpenoid saponins (julibroside 
J29, julibroside J30, julibroside J31), macrocyclic alkaloids 
(budmunchiamines A, B and C) and flavonol glycosides (quercitrin and 
isoquercitrin) [2]. These have shown biological activities such as 
antitumor, antiplatelet aggregation, and bactericidal activities. The 
triterpenoid saponins from Albizia julibrissin bark were found to have 
anticancer activities, and they induced apoptosis in human acute 
leukemia T-cells [4]. Other Albizia species have also been shown to 
have cytotoxicities towards other cancer cell lines [2]. In Ghana, there 
are anecdotal claims by Traditional medicine practitioners that A. 
zygia has anticancer property. These claims have, however, not been 
substantiated scientifically. Earlier phytochemical studies have shown 
that the plant contains lupen-20(30)-en-3β-ol and its glycoside, 
stigmast-5-en-3β-ol, 5α-stigmasta-7, 22-dien-3β-ol, albiziaprenol, 
phytol and flavonoids [3, 5, 6].  
A ten-year review of cancer mortality cases at the Korle-Bu Teaching 
Hospital in Ghana showed that cancer is a major cause of deaths in 
the country and hematopoietic organ, breast, and prostate cancers 
accounted for the highest deaths caused by cancers [7]. Treatment 
options available for cancer include chemotherapy, radiation 
therapy, surgery and biological therapy [8]. Nonetheless, challenges 
associated with these include resistance to therapy, numerous 
adverse side effects due to the treatment procedures and the high 
cost of medication. Thus, there is need for alternative anticancer 
agents which are more efficacious, less toxic and more affordable. 
Efforts have been made to understand the mechanisms of action of 
anticancer agents to guide the production of alternative and more 
effective therapies. A preferred target mechanism for cancer treatment 
is apoptosis, a process of programmed cell death involving various 
morphological changes and eventual cell death [9]. These changes 
include blebbing, cell shrinkage, nuclear fragmentation, chromatin 
condensation and chromosomal DNA fragmentation [10]. 
Mitochondria play an essential role in apoptosis induction by a variety 
of death stimuli. Mitochondrial changes include the loss of the 
mitochondrial membrane potential (∆ψ) and cytochrome C release 
from the mitochondria to the cytosol, which leads to Caspase-9-
dependent activation of caspase-3 resulting finally in apoptosis [11].  
In the present study, we investigated the cytotoxic activity of AZR 
and fractions on Jurkat, LNCap and MCF-7 cells. Furthermore, we 
determined induction of apoptosis by AZR using Jurkat cell line.  
MATERIALS AND METHODS 
Materials and reagents 
RPMI culture medium, Fetal Bovine Serum (FBS), Penicillin-
streptomycin, Trypsin, EDTA, 3-(4,5-Dimethylythiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTT) and 7-Aminoactinomycin D (7-
AAD) were obtained from Sigma Chemical Company (St. Louis, MO, 
USA). RNase A and dimethyl sulfoxide (DMSO) were obtained from 
Wako Pure Chemical Industries (Osaka, Japan) and DNA marker and 
loading dye were purchased from Watson (Japan). Annexin V-
phycoerythrin (PE) was obtained from Molecular Probes (Eugene, 
OR, U. S. A.). The roots of Albizia zygia (Voucher number GC DO 001) 
were collected from the Botanical Gardens of the University of 
Ghana, Ghana, (Geographical coordinates: NO5.657235o 
W000.18751o) in September 2012 and identified by a taxonomist at 
the University of Ghana Herbarium, Accra, where the voucher 
specimen has been kept. The Jurkat, LNCap, MCF-7 and PNT2 cells 
were obtained from the RIKEN BioResource Center Cell Bank 
(Japan). All other chemicals and reagents used were of analytical 
grade and obtained from standard suppliers. 
Preparation of plant extract 
Air-dried and pulverized Albizia zygia root sample was cold-
macerated with 70% ethanol in water (v/v) for 24 h (3X). The 
ethanol content of the extract was removed using a BUCHI® rotary 
evaporator. The remaining aqueous extract was lyophilized 
(LABCONCO®, USA) to obtain the hydroethanolic extract. To obtain 
aqueous extracts, pulverized samples were extracted with distilled 
water at 80 °C for 1 h and centrifuged at 4500 rpm for 20 min at 25 
oC. The supernatant was frozen and lyophilized.  
The petroleum ether, dichloromethane, and ethyl acetate fractions 
were prepared by sequential extraction from the hydroethanolic 
extract as previously described [12, 13]. Subsequently, the organic 
solvents in the fractions were removed under reduced pressure 
using a rotary evaporator (Buchi R-205, Switzerland). 
Cell culture and cytotoxicity assay 
The Jurkat, LNCap and PNT2 cells were cultured in RPMI-1640 and 
MCF-7 in DMEM medium. The media were supplemented with 10% 
fetal bovine serum (FBS) and 1% penicillin-streptomycin. Cultured 
cells were maintained in a humidified incubator at 37 °C in the 
presence of 5% CO2. 
Cytotoxic effects of AZR on the cell lines were determined using the 
MTT assay [14]. Jurkat, LNCap, MCF-7 and PNT2 cells were plated at 
1x104cells/well in a 96 well plate. The cells were treated with 
varying concentrations of the aqueous and hydroethanolic plant 
extracts (0–1000 µg/ml) and dichloromethane, ethyl acetate and 
petroleum ether fractions (0–100 µg/ml). Treated cells were 
incubated as indicated above for 72 h after which 20 µl of MTT 
solution (2.5 mg/ml in PBS) was added to each well and incubation 
was continued for 4 h. Acidified isopropanol containing 1% Triton-X 
was added to each well, and the plates were kept in the dark at room 
temperature to dissolve any formazan crystals formed. The optical 
densities of the wells were measured at 570 nm with a microplate 
reader (Tecan Infinite M200, Austria). The experiments were 
performed in triplicate. 
Cell morphology examination 
The morphology of cultured Jurkat cells was examined after treatment 
of the cells with hydroethanolic AZR extract as earlier described [15]. 
Intact cells were considered viable whilst the presence of fragments 
(apoptotic bodies) was indicative of apoptosis. Jurkat cells were 
seeded into Petri dishes at a density of 1x106 cells/ml. The cells were 
treated with concentrations 2.5 and 5.0 µg/ml of the extract and 
incubated for 24 h at 37 °C. Ursolic acid was used as positive control. 
The nuclear morphology of cells was observed under a fluorescence 
microscope (X40) to determine the degree of cell fragmentation and 
blebs, using Hoechst 33258 staining.  
DNA fragmentation and agarose gel electrophoresis 
DNA fragmentation and agarose gel electrophoresis were performed 
as described by Uto et al. [15]. The Jurkat cells (1x106 cells/ml) were 
treated with hydroethanolic AZR extract at concentrations of 2.5 and 
5.0 µg/ml or 1% ethanolic solution (negative control) for 24 h. 
Ursolic acid was used as positive control. The treated cells were 
washed in ice-cold phosphate buffer saline (PBS) and harvested by 
centrifugation. The pellets were resuspended in a lysis buffer (10 
mM Tris at pH 7.4, 5 mM EDTA, 1% Triton X-100). After 
centrifugation, supernatants were removed, and pellets were 
treated with 1 mg/ml RNase A at 50 °C for 30 min. Cells were then 
treated with 0.1 mg/ml proteinase K at 50 °C overnight. DNA was 
isolated, separated on 2% agarose gel and stained with ethidium 
bromide. DNA band pattern was visualized under UV illumination. 
Measurement of apoptosis by flow cytometry 
A flow cytometer was used to measure apoptotic effect as described by 
Xing et al. [16] with slight modification. Jurkat cells were seeded into 
96-well plates at a concentration of 2 x 105 cell/ml and cultured for 24 
h and treated with hydroethanolic AZR extract, ursolic acid (positive 
control) and 1% ethanolic solution (negative control) for 24 h. The 
cells were treated with equal volumes of guava nexin reagent 
(containing Annexin V-phycoerythrin (PE) and 7-Aminoactinomycin D 
(7-AAD)) and incubated for 20 min in the dark at room temperature 
and analyzed immediately after incubation with a Guava easy Cyte HT 
flow cytometer (Millipore Corporation, U. S. A.). 
Effect of hydroethanolic AZR on mitochondrial membrane 
potential 
Jurkat cells, seeded at a density of 1x 106 cells/6 ml into 6 cm petri 
dishes, were treated with vehicle (negative control), 2.5 µg/ml and 5 
µg/ml of hydroethanolic AZR extract for 16 h. Ursolic acid was used 
as positive control [15]. The cells were stained with 5,5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanine iodide 
(JC-1) solution (a sensitive mitochondrial membrane potential 
probe) and analyzed using a microplate reader (Tecan Infinite 
M200) at wavelength 1: 560 nm (excitation) and 595 nm (emission) 
for red J-aggregate; wavelength 2: 485 nm (excitation) and 535 nm 
(emission) for green JC-1 monomers. 
Phytochemical analysis of extracts 
The presence of alkaloids, saponins, tannins, anthraquinones, 
flavonoids, terpenoids and cardiac glycosides present in the AZR 
were determined using established procedures which have been 
previously described [17]. 
Statistical analysis 
The percent cell viability was calculated using the formula of Ayisi et 
al. [18]. These values were plotted against concentrations of 
extracts, and the concentrations at which 50% inhibitory activities 
were attained (IC50) were determined. The selectivity indices of the 
extracts were also computed as the ratio of the IC50 values in cancer 
cells to that in normal cells. All data are expressed as means of three 
experiments+SD. Significant differences between the control and 
test experiments were determined using Student’s t-test from 
Microsoft Excel 2007 version. P values less than 0.05 was considered 
statistically significant. 
RESULTS  
In the present study, we investigated the cytotoxic activities of 
aqueous and hydroethanolic extracts as well as ethyl acetate, 
dichloromethane and petroleum ether fractions of AZR towards 
Jurkat, LNCap and MCF-7 cells. We also evaluated the potential of 
hydroethanolic AZR extract to induce apoptosis in Jurkat cells. 
Results of the MTT assay (table 1) showed that AZR extracts 
suppressed proliferation of all the cancer cell lines tested. However, 
suppression of cell growth after 72 h of treatment, which was in a 
dose-dependent fashion, was strongest in Jurkat cells followed by 
LNCap cells. The extract showed weaker suppressive effects in MCF-
7 cells. The AZR extracts had rather weak inhibitory effects on the 
proliferation of PNT2 thus translating into very good SI values of 
AZR for both Jurkat and LNCap cells (table 1). 
The data in table 2 shows that treatment of the cell lines with ethyl 
acetate, dichloromethane, and petroleum ether fractions generally 
resulted in the weak or non-inhibitory effect on proliferation of 
Jurkat and LNCap cells. In contrast, the proliferation of MCF-7 cell 
was significantly inhibited following treatment with petroleum ether 
fraction of AZR, resulting in a selectivity index of 2.4. 
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Table 1: Cytotoxicity and selectivity indices of AZR extracts in cancer cell lines 
Plant extracts IC50 values (µg/ml) 
Jurkat  LNCap MCF-7 
Aqueous 3.09+0.05 (104.4) 35.8+0.08*(9.0) 445.5+39.39* (0.72) 
Hydroethanolic 3.37+0.112 (83.6) 6.08+0.91 (46.4) 377.5+3.81* (0.75) 
Curcumin 1.42+0.11 (3.35) 4.02+1.42 (1.18) 2.56+0.82 (1.86) 
IC50 values are means+SD Experiments in triplicate (n=3). Curcumin was used as positive control. Values in parenthesis are SI values. *P<0.05 shows 
a significant difference in IC50 values compared to values obtained for curcumin. 
 
Table 2: Cytotoxicity and selectivity indices of AZR fractions in cancer cell lines 
Plant fractions IC50 values (µg/ml) 
Jurkat  LNCap MCF-7 
Ethyl acetate 91.4+4.25* (1.09) >100.0 92.2+10.82* (1.09) 
Dichloromethane >100.0 >100.0 >100.0 
Petroleum ether >100.0 >100.0 41.5+2.4* (2.41) 
Curcumin 1.42+0.11 (3.35) 4.02+1.42 (1.18) 2.56+0.82 (1.86) 
IC50 values are means+SD Experiments in triplicate (n=3). Curcumin was used as positive control. Values in parenthesis are SI values. *P<0.05 shows 
a significant difference in IC50 values compared to values obtained for curcumin. 
 
Results obtained for apoptosis are presented in fig. 1-4. Jurkat cells 
treated with hydroethanolic AZR extract had marked nuclear 
condensation and more apoptotic bodies compared to the negative 
control cells which had normal nuclear morphology with very few 
apoptotic bodies (fig. 1A-C).  
 
 
Fig. 1: Apoptotic effect of hydroethanolic extract of AZR in 
Jurkat cells 
 
Cells were cultured in the presence of the negative control (1% 
ethanolic solution, A), 2.5 μg/ml (B) and 5.0 μg/ml (C) of the extract, 
respectively. Magnification-X40. 
Further studies showed the presence of significant DNA fragmentation 
in Jurkat cells when treated with the extract for 24 h (fig. 2).  
 
 
Fig. 2: DNA fragmentation in Jurkat cells 
 
Fig. shows DNA from untreated cells, negative control (A), cells 
treated with AZR extract 2.5 mg/ml (B) and 5.0 μg/ml of (C) for 24 
h, and analyzed by agarose gel electrophoresis. Lane (M) is the 100-
bp DNA marker; 0, negative control. 
Flow cytometric assays following Annexin V-PE and 7-AAD dual 
staining showed that the sum of early and late apoptosis following 
treatment with 2.5 µg/ml (B) and 5.0 µg/ml (C) of the extract were 
20.4% and 25%, respectively i.e.>2 fold the level of apoptosis in the 
negative control (A) (fig. 3). Results of the effect of the extract on 
mitochondrial membrane potential presented in fig. 4 shows 




Fig. 3: Flow cytometric plots showing apoptotic effects of 
hydroethanolic extract of AZR in Jurkat cells 
 
The fig. shows plots for untreated cells (A), cells treated with 2.5 
μg/ml (B), and 5.0 μg/ml (C) of the extract for 24 h. 
Cells were treated with 2.5 µg/ml, 5 µg/ml of AZR and 1% ethanolic 
solution (negative control). ‘*’ represents a significant difference 
(ρ<0.05) compared to the control experiment. 
Results on phytochemical analysis of the hydroethanolic AZR extract 
showed the presence of alkaloids, saponins, tannins, flavonoids, 
cardiac glycosides and terpenoids. Anthraquinones were not 
detected in the extract. 
Appiah-Opong et al. 
















































Fig. 4: Mitochondrial membrane potential of Jurkat cells treated with hydroethanolic extract of AZR 
Jurkat cells were cultured in the presence of 2.5 µg/ml, 5 µg/ml of AZR and 1% ethanolic solution (negative control) for 16 h, stained with JC-1 
solution and analyzed using fluorescence spectrophotometry. RFU, relative fluorescence units; *, ρ < 0.05 compared to control experiment. 
 
DISCUSSION 
Earlier studies have reported antitumor and cytotoxic activities of 
some secondary metabolites in Albizia species and their derivatives 
[2, 19]. Aqueous and ethanolic leaf extracts of Albizia amara was 
found to be cytotoxic to MCF-7 cells with IC50 values of 83.16 µg/ml 
and 57.54 µg/ml, respectively, while ethyl acetate extract showed 
stronger cytotoxicity (36.31 µg/ml) [19]. Methanolic leaf extract of 
Albizia lebbeck also showed nearly 50% inhibition of MCF-7 cells at a 
concentration of 200 µg/ml [20]. In the present study, we 
investigated the cytotoxic effect of aqueous and hydroethanolic 
extracts as well as the ethyl acetate, dichloromethane and petroleum 
ether fractions of AZR towards Jurkat, LNCap and MCF-7 cells. AZR 
extracts exhibited a cytotoxic effect on the cell lines investigated. 
The effects were, however, more pronounced on Jurkat cells 
followed by LNCap cells suggesting some level of selectivity. 
Determination of in vitro cytotoxicity and selectivity is very 
important in identifying new medicinal products with potential as 
anticancer agents. We also evaluated the potential of hydroethanolic 
AZR extract to induce apoptosis in the cells. 
Aqueous and hydroethanolic extracts of AZR showed rather weak 
cytotoxicities towards MCF-7 cells compared to the activity reported 
on Albizia amara, however, petroleum ether and ethyl acetate 
fractions showed stronger and comparable activities. The SI of 2.4 
recorded for MCF-7 cells treated with petroleum ether was 
significant. The aqueous and hydroethanolic extracts exhibited the 
strongest cytotoxicities in Jurkat cells comparable with the positive 
control (curcumin) with SI values greater than 80. Both extracts also 
showed strong cytotoxicity towards LNCap cells, but the 
hydroethanolic extracts showed 6 times stronger activity than the 
aqueous extract. With the exception of the ethyl acetate fraction that 
showed cytotoxicity towards both Jurkat and MCF-7 cells and 
petroleum ether fraction that was cytotoxic towards the latter, no 
other significant inhibition by fractions on the cells was recorded. 
Medicinal products with SI values of 2 or greater than 2 are 
considered to have significant therapeutic effects [21]. These results 
suggest that the cytotoxic constituents of AZR extracted into 
aqueous and hydroethanolic extracts, petroleum ether and ethyl 
acetate fractions and not the dichloromethane fraction. Isolation and 
characterization of the active component(s) from the hydroethanolic 
extract and the petroleum ether fraction are currently underway.  
Available evidence shows that a number of the cytotoxic anticancer 
drugs generally induce apoptosis in susceptible cells via interaction 
with a number of targets and activate genes and processes that 
modulate 'programmed' cell death [22]. The marked nuclear 
condensation and observed apoptotic bodies in the AZR extract 
treated Jurkat cells compared to control cells suggested that 
hydroethanolic extract of AZR mediated the induction of apoptosis 
in the cells. Results on the DNA fragmentation/laddering (fig. 2) also 
showed that the extract is induced apoptosis in the Jurkat cells. 
Interestingly, the flow cytometric analysis (fig. 3) confirmed that 
apoptosis was induced in the cancer cells after treatment with the 
extract. Studies on Albizia julibrissin bark also suggested that it has 
anticancer activities and induces apoptosis in human acute leukemia 
T-cells [4].  
Our study has shown that AZR extract significantly caused 
mitochondrial dysfunction as shown by the reduction in J-aggregates 
formation and increases in JC-1 monomeric forms in the presence of 
the extract (fig. 4). Mitochondrial dysfunction is characteristic of the 
intrinsic apoptosis pathway [11]. These results are consistent with 
other reports that show that apoptosis is associated with 
mitochondrial dysfunction, nuclear morphological changes and DNA 
fragmentation [10, 11]. Indeed, a recent study involving systems-
level analysis has revealed that anticancer agents produce dynamic 
rewiring of oncogenic signaling pathways to make cells less 
tumorigenic and more susceptible to DNA damage-induced cell 
death via the reactivation of a suppressed extrinsic apoptotic 
pathway [23]. 
In this study, the hydroethanolic AZR extract was shown to contain 
alkaloids, saponins and flavonoids and other secondary metabolites 
previously reported to be present leaves of the plant and also in 
other Albizia species that have exhibited cytotoxicity [3, 24]. It is 
significant to note that some flavonoids, alkaloids and saponins have 
been reported to possess anticancer activities among others [25-27]. 
The presence of these components in AZR may account for the 
cytotoxic activity of AZR. 
CONCLUSION 
In conclusion, this study has shown that AZRE possesses potential 
anticancer activity and has demonstrated a high selective toxicity 
against Jurkat cells. Furthermore, the extract induced apoptosis in 
the Jurkat cells. Albizia zygia roots, therefore, may be a source of 
novel compounds for the development of new anti-cancer agents. 
Further studies are underway to identify the compound(s) in the 
extract that are responsible for the cytotoxic activity and establishes 
their mechanism(s) of action. 
ABBREVIATION 
MTT, 3-(4,5-Dimethylythiazol-2-yl)-2,5-diphenyltetrazolium bromide; 
AZRE, Albizia zygia root hydroethanolic extract; EDTA, 
ethylenediaminetetraacetic acid; Annexin V-PE, Annexin V-
Phycoerythrin; 7-AAD, 7-Aminoactinomycin D; PBS, phosphate buffer 
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